CHA
GWPH

Carmichael Hill & Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Carmichael Hill & Associates’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-109
Closed -$24K – 802
2021
Q1 		$24K Hold
109
– – 0.01% 476
2020
Q4 		$13K Hold
109
– – 0.01% 540
2020
Q3 		$11K Hold
109
– – 0.01% 523
2020
Q2 		$13K Hold
109
– – 0.01% 475
2020
Q1 		$10K Hold
109
– – 0.01% 469
2019
Q4 		$11K Buy
+109
New +$12.2K 0.01% 482

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Carmichael Hill & Associates's GWPH Position: Q2 2021 in Review

Carmichael Hill & Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 109 shares — an estimated $24K sold.

Carmichael Hill & Associates first reported a position in GWPH in Q4 2019 and held it in 6 quarters. The position peaked at $24K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Carmichael Hill & Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Carmichael Hill & Associates sold 109 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $24K.
  • Carmichael Hill & Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 6 quarters.
  • Carmichael Hill & Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $24K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Carmichael Hill & Associates's 13F filing for Q2 2021, filed 3 Aug 2021.